论文部分内容阅读
急性心肌梗塞(AMI)为三大病死率高发病之一。目前,国外虽然有溶栓治疗能降低AMI的病死率的报导,但国内治疗尚未获突破性进展。根据黑龙江省卫生厅责承哈尔滨医科大学附属第一医院内科心血管病研究所举办的“推广应用硝普钠多巴胺治
Acute myocardial infarction (AMI) is one of the three high fatality rates. At present, although thrombolytic therapy in foreign countries can reduce the mortality of AMI reports, but the domestic treatment has not been a breakthrough. According to the responsibility of Heilongjiang Provincial Department of Health Cheng Harbin Medical University Affiliated Hospital Cardiovascular Institute held the "promotion of sodium nitroprusside dopamine